IL325331A - Tyk2 inhibitors, compositions containing them and their uses - Google Patents

Tyk2 inhibitors, compositions containing them and their uses

Info

Publication number
IL325331A
IL325331A IL325331A IL32533125A IL325331A IL 325331 A IL325331 A IL 325331A IL 325331 A IL325331 A IL 325331A IL 32533125 A IL32533125 A IL 32533125A IL 325331 A IL325331 A IL 325331A
Authority
IL
Israel
Prior art keywords
compositions
methods
tyk2 inhibitors
tyk2
inhibitors
Prior art date
Application number
IL325331A
Other languages
English (en)
Hebrew (he)
Inventor
Li Xiaodong
Su Lin
Wan Zhaokui
Grewal Gurmit
Lawrence Vazquez Michael
Lin Weiyu
Original Assignee
Lynk Pharmaceuticals Co Ltd
Li Xiaodong
Su Lin
Wan Zhaokui
Grewal Gurmit
Lawrence Vazquez Michael
Lin Weiyu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lynk Pharmaceuticals Co Ltd, Li Xiaodong, Su Lin, Wan Zhaokui, Grewal Gurmit, Lawrence Vazquez Michael, Lin Weiyu filed Critical Lynk Pharmaceuticals Co Ltd
Publication of IL325331A publication Critical patent/IL325331A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL325331A 2023-06-15 2025-12-14 Tyk2 inhibitors, compositions containing them and their uses IL325331A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2023/100508 WO2024254832A1 (fr) 2023-06-15 2023-06-15 Inhibiteurs de tyk2 et compositions et procédés associés
PCT/CN2024/099407 WO2024255886A1 (fr) 2023-06-15 2024-06-14 Inhibiteurs de tyk2, compositions et procédés associés

Publications (1)

Publication Number Publication Date
IL325331A true IL325331A (en) 2026-02-01

Family

ID=93851118

Family Applications (1)

Application Number Title Priority Date Filing Date
IL325331A IL325331A (en) 2023-06-15 2025-12-14 Tyk2 inhibitors, compositions containing them and their uses

Country Status (8)

Country Link
EP (1) EP4727935A1 (fr)
JP (1) JP2026521561A (fr)
KR (1) KR20260049523A (fr)
CN (1) CN121843931A (fr)
AU (1) AU2024304652A1 (fr)
IL (1) IL325331A (fr)
TW (1) TW202502764A (fr)
WO (2) WO2024254832A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013047813A1 (fr) * 2011-09-30 2013-04-04 大鵬薬品工業株式会社 Dérivé de 1,2,4-triazine-6-carboxamide
WO2013117649A1 (fr) * 2012-02-10 2013-08-15 Galapagos Nv Dérivés d'imidazo [4, 5-c] pyridine utiles pour le traitement de maladies dégénératives et inflammatoires
US9040530B2 (en) * 2012-06-22 2015-05-26 Portola Pharmaceuticals, Inc. 1,2,4-triazine-6-carboxamide kinase inhibitors
EP3181564B1 (fr) * 2012-11-20 2019-09-18 H. Hoffnabb-La Roche Ag Composés d'aminopyrimidine comme inhibiteurs de mutants egfr de t790m
CN111484480B (zh) * 2019-01-29 2023-08-11 上海翰森生物医药科技有限公司 一种多环类衍生物抑制剂、其制备方法和应用
TW202317561A (zh) * 2021-07-01 2023-05-01 美商羅曼德生物治療公司 作為治療劑的具有1h—吡唑并[4,3—c]吡啶—6—胺基的化合物
TW202339749A (zh) * 2021-12-16 2023-10-16 大陸商凌科藥業有限公司 Tyk2抑制劑及其組合物和方法

Also Published As

Publication number Publication date
JP2026521561A (ja) 2026-06-30
EP4727935A1 (fr) 2026-04-22
TW202502764A (zh) 2025-01-16
KR20260049523A (ko) 2026-04-14
CN121843931A (zh) 2026-04-10
AU2024304652A1 (en) 2026-01-22
WO2024255886A1 (fr) 2024-12-19
WO2024254832A1 (fr) 2024-12-19

Similar Documents

Publication Publication Date Title
EP4448514A4 (fr) Inhibiteurs de tyk2 et compositions et procédés associés
IL326350A (en) Benzopyridinones and benzopyrimidinones as pi3k inhibitors
IL318706A (en) Compositions and methods for inducing proptosis
IL315862A (en) Angiotensinogen modulators and methods of using them
IL319049A (en) TYK2 inhibitors and their uses
AU2024391389A1 (en) Tyk2 inhibitors and uses thereof
GB202316199D0 (en) Compositions and methods and uses thereto
GB202209588D0 (en) Methods and compositions
GB202217944D0 (en) Compositions and method
CA3295315A1 (fr) Inhibiteurs de tyk2, compositions et procédés associés
CA3295318A1 (fr) Inhibiteurs de tyk2 et compositions et procédés associés
GB2635318B (en) Methods and compositions
IL317852A (en) 3-βHSD1 inhibitors and compositions and uses thereof
IL321428A (en) Compounds and methods
GB202316109D0 (en) Methods and compositions
GB202311858D0 (en) Methods and compositions
GB202308901D0 (en) Methods and compositions
GB202211117D0 (en) Compositions and methods for non-immunogenecity
GB202305427D0 (en) Methods and compositions
GB202304240D0 (en) Compositions and methods
IL315882A (en) Antibodies against ILT4, preparations and methods
GB202219851D0 (en) Compositions and methods
GB202206268D0 (en) Compositions and methods
GB202205579D0 (en) Methods and compositions
GB202306393D0 (en) Trna-based methods and related compositions